Dr Ligia M Belalcazar, MD in Galveston, TX - Medicare Endocrinology

Dr Ligia M Belalcazar, MD is a medicare enrolled "Internal Medicine - Endocrinology, Diabetes & Metabolism" physician in Galveston, Texas. She went to University Of Missouri, Columbia School Of Medicine and graduated in 1986 and has 38 years of diverse experience with area of expertise as Endocrinology. She is a member of the group practice University Of Texas Medical Branch Faculty Group Practice and her current practice location is 301 University Blvd, Galveston, Texas. You can reach out to her office (for appointments etc.) via phone at (409) 772-2222.

Dr Ligia M Belalcazar is licensed to practice in Texas (license number K2646) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1568521375.

Contact Information

	Dr Ligia M Belalcazar, MD
	301 University Blvd, Galveston, TX 77555-5302
	(409) 772-2222
	Not Available

Physician's Profile

Full Name	Dr Ligia M Belalcazar
Gender	Female
Speciality	Endocrinology
Experience	38 Years
Location	301 University Blvd, Galveston, Texas
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Ligia M Belalcazar attended and graduated from University Of Missouri, Columbia School Of Medicine in 1986

NPI Data:

NPI Number: 1568521375
Provider Enumeration Date: 12/07/2006
Last Update Date: 05/18/2009

Medicare PECOS Information:

PECOS PAC ID: 7517095227
Enrollment ID: I20100517000260

Medical Identifiers

Medical identifiers for Dr Ligia M Belalcazar such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1568521375	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RE0101X	Internal Medicine - Endocrinology, Diabetes & Metabolism	K2646 (Texas)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
University Of Texas Medical Branch Galveston	Galveston, TX	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
University Of Texas Medical Branch Faculty Group Practice	3375456734	875

News Archive

NormOxys raises $17.5M in Series B financing round

NormOxys, Inc., a biotechnology company developing a novel class of small molecule drugs which enhance the body's ability to deliver oxygen to diseased tissues, today announced that it has raised $17.5 million in a Series B financing round. The financing was led by a new investor, Care Capital, LLC, with participation from existing venture investor Index Ventures.

New methods reduce mother-to-child transmission of HIV from 23.9% to 2.4% in Gipuzkoa

Miren Apilánez, researcher in the Department of Paediatrics of the UPV/EHU-University of the Basque Country, has studied the evolution that took place between 1984 and 2011 in paediatric HIV infection in Gipuzkoa. The development of methods to diagnose the disease coupled with increasingly more effective treatments have made it possible to reduce mother-to-child transmission (vertical transmission) from 23.9% to 2.4%, thus virtually eradicating infection in children.

Advances in gene therapy for inherited blood disorders

Gene therapy holds a lot of promise in medicine. If we could safely alter our own DNA, we might eliminate diseases our ancestors passed down to us.

Prana's PBT2 drug recognised as one of the most promising treatments under development

Prana Biotechnology, a leading global developer of first-in-class treatments for neurodegenerative disease, is pleased to announce Elsevier Business Intelligence has named clinical drug PBT2 as one of the Top 10 Neuroscience Projects to Watch.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Ligia M Belalcazar allows following entities to bill medicare on her behalf.

Entity Name	Utmb Faculty Group Practice
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1942241146 PECOS PAC ID: 3375456734 Enrollment ID: O20031112000438

News Archive

NormOxys raises $17.5M in Series B financing round

New methods reduce mother-to-child transmission of HIV from 23.9% to 2.4% in Gipuzkoa

Advances in gene therapy for inherited blood disorders

Gene therapy holds a lot of promise in medicine. If we could safely alter our own DNA, we might eliminate diseases our ancestors passed down to us.

Prana's PBT2 drug recognised as one of the most promising treatments under development

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Ligia M Belalcazar is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Ligia M Belalcazar, MD 301 University Blvd, Galveston, TX 77555-5302 Ph: (409) 772-2222	Dr Ligia M Belalcazar, MD 301 University Blvd, Galveston, TX 77555-5302 Ph: (409) 772-2222

News Archive

NormOxys raises $17.5M in Series B financing round

New methods reduce mother-to-child transmission of HIV from 23.9% to 2.4% in Gipuzkoa

Advances in gene therapy for inherited blood disorders

Gene therapy holds a lot of promise in medicine. If we could safely alter our own DNA, we might eliminate diseases our ancestors passed down to us.

Prana's PBT2 drug recognised as one of the most promising treatments under development

Internal Medicine Doctors in Galveston, TX

Dr. James Harold Pavela, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-7063 Fax: 409-747-8579
Diaa Hamouda, MBBCH Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Jsa 9.128, Galveston, TX 77555 Phone: 409-772-8031 Fax: 409-772-6940
Syed Mustajab Hasan, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1005 Harborside Drive, Galveston, TX 77555 Phone: 409-762-2328 Fax: 832-632-7866
Arielle Degueure, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-747-1883 Fax: 409-747-8579
Dr. Shawn Pua Eiko Nishi, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-643-4587
Suyuan Tan, Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-747-1883
Shahzad Jokhio, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-722-2222

Dr Ligia M Belalcazar, MD - Medicare Endocrinology in Galveston, TX

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

NormOxys raises $17.5M in Series B financing round

New methods reduce mother-to-child transmission of HIV from 23.9% to 2.4% in Gipuzkoa

Advances in gene therapy for inherited blood disorders

Prana's PBT2 drug recognised as one of the most promising treatments under development

Medicare Reassignments

NormOxys raises $17.5M in Series B financing round

New methods reduce mother-to-child transmission of HIV from 23.9% to 2.4% in Gipuzkoa

Advances in gene therapy for inherited blood disorders

Prana's PBT2 drug recognised as one of the most promising treatments under development

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

NormOxys raises $17.5M in Series B financing round

New methods reduce mother-to-child transmission of HIV from 23.9% to 2.4% in Gipuzkoa

Advances in gene therapy for inherited blood disorders

Prana's PBT2 drug recognised as one of the most promising treatments under development

Internal Medicine Doctors in Galveston, TX